Recent advances of m6A methylation in skeletal system disease
Abstract Skeletal system disease (SSD) is defined as a class of chronic disorders of skeletal system with poor prognosis and causes heavy economic burden. m6A, methylation at the N6 position of adenosine in RNA, is a reversible and dynamic modification in posttranscriptional mRNA. Evidences suggest...
Main Authors: | Jianhui Liang, Qian Yi, Yang Liu, Jiachen Li, Zecheng Yang, Wei Sun, Weichao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-04944-y |
Similar Items
-
The role of retinoic acid receptor-related orphan receptors in skeletal diseases
by: Yifan Zhang, et al.
Published: (2023-11-01) -
The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome
by: Zheng H, et al.
Published: (2023-11-01) -
Emerging roles and mechanism of m6A methylation in rheumatoid arthritis
by: Yayun Xu, et al.
Published: (2024-01-01) -
The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
by: Yanjiao Wu, et al.
Published: (2022-04-01) -
Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system
by: Zicai Dong, et al.
Published: (2023-05-01)